General Information of Drug Off-Target (DOT) (ID: OTYW7ED8)

DOT Name Rho GTPase-activating protein 25 (ARHGAP25)
Synonyms Rho-type GTPase-activating protein 25
Gene Name ARHGAP25
Related Disease
Type-1 diabetes ( )
Lung cancer ( )
Lung carcinoma ( )
Colorectal carcinoma ( )
UniProt ID
RHG25_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1V89
Pfam ID
PF00169 ; PF00620
Sequence
MSLKLPRNWDFNLKVEAAKIARSRSVMTGEQMAAFHPSSTPNPLERPIKMGWLKKQRSIV
KNWQQRYFVLRAQQLYYYKDEEDTKPQGCMYLPGCTIKEIATNPEEAGKFVFEIIPASWD
QNRMGQDSYVLMASSQAEMEEWVKFLRRVAGTPCGVFGQRLDETVAYEQKFGPHLVPILV
EKCAEFILEHGRNEEGIFRLPGQDNLVKQLRDAFDAGERPSFDRDTDVHTVASLLKLYLR
DLPEPVVPWSQYEGFLLCGQLTNADEAKAQQELMKQLSILPRDNYSLLSYICRFLHEIQL
NCAVNKMSVDNLATVIGVNLIRSKVEDPAVIMRGTPQIQRVMTMMIRDHEVLFPKSKDIP
LSPPAQKNDPKKAPVARSSVGWDATEDLRISRTDSFSSMTSDSDTTSPTGQQPSDAFPED
SSKVPREKPGDWKMQSRKRTQTLPNRKCFLTSAFQGANSSKMEIFKNEFWSPSSEAKAGE
GHRRTMSQDLRQLSDSQRTSTYDNVPSLPGSPGEEASALSSQACDSKGDTLASPNSETGP
GKKNSGEEEIDSLQRMVQELRKEIETQKQMYEEQIKNLEKENYDVWAKVVRLNEELEKEK
KKSAALEISLRNMERSREDVEKRNKALEEEVKEFVKSMKEPKTEA
Function GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state.
Reactome Pathway
RAC1 GTPase cycle (R-HSA-9013149 )

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Type-1 diabetes DIS7HLUB Definitive Biomarker [1]
Lung cancer DISCM4YA Strong Altered Expression [2]
Lung carcinoma DISTR26C Strong Altered Expression [2]
Colorectal carcinoma DIS5PYL0 moderate Altered Expression [3]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Rho GTPase-activating protein 25 (ARHGAP25). [4]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Rho GTPase-activating protein 25 (ARHGAP25). [5]
------------------------------------------------------------------------------------

References

1 Comparative analysis of gene expression profiles in children with type 1 diabetes mellitus.Mol Med Rep. 2019 May;19(5):3989-4000. doi: 10.3892/mmr.2019.10099. Epub 2019 Mar 28.
2 The tumor suppressive roles of ARHGAP25 in lung cancer cells.Onco Targets Ther. 2019 Aug 19;12:6699-6710. doi: 10.2147/OTT.S207540. eCollection 2019.
3 Weichang'an suppressed migration and invasion of HCT116 cells by inhibiting Wnt/-catenin pathway while upregulating ARHGAP25.Biotechnol Appl Biochem. 2019 Sep;66(5):787-793. doi: 10.1002/bab.1784. Epub 2019 Aug 19.
4 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
5 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.